This week in the Product Spotlight: An Exhaustive Look at Diabetes Research Products

With the World Health Organization (WHO) predicting that diabetes will be the seventh-leading cause of death worldwide by 2030, diabetes research is of increasing importance.1 This week we are pleased to present a selection of new products for diabetes and obesity research, offered by Peptides International:

  • Anti GIP (Rat) Serum NAY-8102-v
  • Anti GIP (18–42) (Rat) Serum NAY-8103-v
    Gastric inhibitory polypeptide (GIP) helps stimulate insulin secretion.
  • Insulin I (Rat, Mouse) PIN-4501-v
  • Insulin II (Rat, Mouse) PIN-4502-v
    Insulin, a peptide hormone secreted by the islet cells in the pancreas, is responsible for the body’s ability to effectively process sugar.  
  • Pancreastatin (Dephosphorylated Porcine) PAN-3978-PI
    Pancreastatin has been found to inhibit insulin secretion.

Diabetes Research Products related to this week’s PepTalk:

For further reading on Diabetes, we invite you to take a look at our newly updated Diabetes Research Products brochure. For discounts on bulk quantities, please inquire for a bulk quotation. Does your research require something not commercially available? Peptides International can custom synthesize a peptide to suit your needs.

  1. http://www.who.int/mediacentre/factsheets/fs312/en/

The entire archive of Peptides International Product Spotlights are available here.  The topics range from some of the most popular items we have available to those lesser known ones that still have compelling research applications.  They often are chosen due to recently published articles that feature them.  They are permanently posted here, so read at your leisure!

laptop